1. Telomerase promoter mutations in cancer: an emerging molecular biomarker?

   • João Vinagre
   • Vasco Pinto
   • Paula Soares

   Review and Perspectives 22 July 2014 Pages: 119 - 133

2. Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett’s esophagus

   • David R. Braxton
   • Dana C. Nickleach
   • Alton B. Farris III

   Original Article 27 May 2014 Pages: 135 - 143

   

3. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma

   • Hiroshi Yoshida
   • Noriko Yamamoto
   • Hitoshi Tsuda

   Original Article 03 June 2014 Pages: 145 - 154

   

4. Invasion pattern and histologic features of tumor aggressiveness correlate with MMR protein expression, but are independent of activating KRAS and BRAF mutations in CRC

   • Konrad Steinestel
   • Jochen K. Lennerz
   • Annette Arndt

   Original Article 12 June 2014 Pages: 155 - 163

   

5. Non-sarcomatous spindle cell morphology in conventional lung adenocarcinoma: a clinicopathological study

   • Susumu Matsukuma
   • Kiyohaya Obara
   • Kimiya Sato

   Original Article 31 May 2014 Pages: 165 - 172

   

6. Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors

   • V. Pulkkinen
   • S. Ezer
   • J. Arola

   Original Article Open access 12 June 2014 Pages: 173 - 183

   

7. Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype

   • Miguel Rito
   • Fernando Schmitt
   • Saudade André

   Original Article 06 June 2014 Pages: 185 - 191

   

8. Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma

   • Gian Franco Zannoni
   • Giuseppina Improta
   • Filippo Fraggetta

   Original Article 03 June 2014 Pages: 193 - 198

   

9. Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder

   • Antonio Lopez Beltran
   • Liang Cheng
   • Eva Comperat

   Original Article 31 May 2014 Pages: 199 - 205

   

10. FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer

    • Yann Neuzillet
    • Bas W. G. van Rhijn
    • Theo H. van der Kwast

    Original Article 01 June 2014 Pages: 207 - 213

    

11. Foamy cell (hibernoma-like) change is a rare histopathological feature in renal cell carcinoma

    • Fredrik Petersson
    • Maris Sperga
    • Ondrej Hes

    Original Article 06 June 2014 Pages: 215 - 224

    

12. Limited role for histopathological examination of re-excision specimens of completely excised melanomas

    • A. C. de Waal
    • R. Vossen
    • W. A. M. Blokx

    Original Article 29 May 2014 Pages: 225 - 231

    

13. Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion

    • Navid Sadri
    • Julieta Barroeta
    • Paul J. Zhang

    Case Report 04 July 2014 Pages: 233 - 239

    

14. Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation

    • Ryan S. Berry
    • Rama R. Gullapalli
    • Joshua A. Hanson

    Case Report 06 July 2014 Pages: 241 - 245

    

15. Is morphology alone able to predict BRAF-mutated malignancies on thyroid FNAC?

    • Esther Diana Rossi
    • Tommaso Bizzarro
    • Fernando Schmitt

    Letter to the Editor 14 June 2014 Pages: 247 - 248

    

16. Authors’ response

    • Manju L. Prasad
    • Renu K. Virk

    Letter to the Editor 28 June 2014 Pages: 249 - 249

17. Erratum to: “Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors

    • V. Pulkkinen
    • S. Ezer
    • J. Arola

    Erratum 03 July 2014 Pages: 251 - 251